Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells.
Doxorubicin is a first-line chemotherapeutic for breast cancer; however, it is associated with severe side effects to non-tumoral tissues. Thus, it is necessary to develop new therapeutic combinations to improve doxorubicin effects at lower concentration of the drug associated with protective effects for non-tumoral cells. In this work, we evaluated whether the plant-derived flavonoid quercetin may represent such an agent.
Version: za2963e q8za0 q8zb8 q8zc8 q8zd2 q8ze7 q8zf8 q8zg4